1309868-83-4Relevant academic research and scientific papers
Controlling the formation of heliconical smectic phases by molecular design of achiral bent-core molecules
Alaasar, Mohamed,Cai, Xiaoqian,Eremin, Alexey,Kurachkina, Marharyta,Lehmann, Anne,Liu, Feng,Nagaraj, Mamatha,Poppe, Marco,Poppe, Silvio,Tamba, Maria-Gabriela,Tschierske, Carsten,Vij, Jagdish K.
, p. 3316 - 3336 (2020/03/23)
Fluids with spontaneous helical structures formed by achiral low molecular mass molecules is a newly emerging field with great application potential. Here, we explore the chemical mechanisms of the helix formation by systematically modifying the structure of a bent 4-cyanoresorcinol unit functionalized with two different phenyl benzoate based aromatic rods and terminated with two alkyl chains of variable length. The majority of these achiral compounds self-assemble, forming a short-pitch heliconical liquid crystalline phase in broad temperature ranges. In some cases, it occurs without any competing low-temperature phase. We demonstrate that the mirror symmetry broken mesophase occurs at the paraelectric-(anti)ferroelectric transition if the tilt angle of the molecules in the smectic layers is around 18-20° and if this transition coincides with a change of the tilt correlation between the layers. In the close vicinity of this transition, a field-induced heliconical phase develops as well as a new heliconical phase with polarization-randomized structure. These investigations provide a blueprint for the future design of achiral molecules capable of spontaneous mirror symmetry breaking by the formation of heliconical liquid crystalline phases.
Discovery, biological evaluation, and structure-activity relationship of amidine based sphingosine kinase inhibitors
Mathews, Thomas P.,Kennedy, Andrew J.,Kharel, Yugesh,Kennedy, Perry C.,Nicoara, Oana,Sunkara, Manjula,Morris, Andrew J.,Wamhoff, Brian R.,Lynch, Kevin R.,MacDonald, Timothy L.
experimental part, p. 2766 - 2778 (2010/09/04)
Sphingosine 1-phosphate (S1P), a potent phospholipid growth and trophic factor, is synthesized in vivo by two sphingosine kinases. Thus these kinases have been proposed as important drug targets for treatment of hyperproliferative diseases and inflammation. We report here a new class of amidine-based sphingosine analogues that are competitive inhibitors of sphingosine kinases exhibiting varying degrees of enzyme selectivity. These inhibitors display KI values in the submicromolar range for both sphingosine kinases and, in cultured vascular smooth muscle cells, decrease S1P levels and initiate growth arrest.
